The government is set to begin a nationwide rollout of a long-acting HIV prevention injection, Cabotegravir (CAB-LA), this week, following a successful one-year pilot phase. The rollout aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results